Price and institutional trades
$9.77−72.3%1Y
DecJanFebMarAprMayJunJulAugSepOctNov
Holders
$65M · direct 38.79% · indirect 0.29% · 2026-09-1839.08%
- Direct38.79%
- KolonGlobal 72.70% → Kolon TissueGene 0.40%0.29%
$56M · direct 13.91% · indirect 19.81% · 2026-09-1833.72%
- Direct13.91%
- KolonGlobal 9.14% → Kolon TissueGene 0.40%0.04%
- Kolon 50.60% → KolonGlobal 72.70% → Kolon TissueGene 0.40%0.15%
- Kolon 50.60% → Kolon TissueGene 38.79%19.63%
$16M · 2026-09-189.74%
$3.4M · 2026-09-182.01%
+5 other related parties$1.8M1.06%
Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.
Indirect-only holders
$559K · indirect0.33%
- 3.43% → Kolon TissueGene 9.74%
Filings
| Filed | Changed | Holder | Change | Before → after | Amount | Avg buy price | |
|---|
| 2026-09-18 | 2026-09-18 | | | 65.79 → 65.51% | - | - |
| 2026-07-31 | 2026-07-28 | | | 65.78 → 65.79% | +$73K | $55.89 |
| 2026-07-28 | 2026-07-27 | | | 65.99 → 65.78% | −$71K | $57.19 |
| 2026-05-15 | - | | | 38.99 → 38.94% | −$782K | - |
| 2026-03-30 | - | | | 39.84 → 38.99% | +$45M |
10 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched
